Burning Rock Biotech Limited
BNR
$23.00
$0.251.10%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.33% | 4.56% | 4.47% | 4.47% | 2.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.33% | 4.56% | 4.47% | 4.47% | 2.03% |
| Cost of Revenue | -10.92% | -11.80% | -14.51% | -14.51% | -10.60% |
| Gross Profit | 7.64% | 12.19% | 14.90% | 14.90% | 8.15% |
| SG&A Expenses | -9.55% | -51.04% | -50.77% | -50.77% | -54.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.63% | -41.80% | -39.64% | -39.64% | -44.78% |
| Operating Income | 58.19% | 88.09% | 71.76% | 71.76% | 78.17% |
| Income Before Tax | 53.44% | 89.20% | 52.67% | 52.67% | 79.40% |
| Income Tax Expenses | 5.34% | 22.71% | 398.11% | 398.11% | -54.75% |
| Earnings from Continuing Operations | 53.11% | 89.04% | 49.70% | 49.70% | 79.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.11% | 89.04% | 49.70% | 49.70% | 79.33% |
| EBIT | 58.19% | 88.09% | 71.76% | 71.76% | 78.17% |
| EBITDA | 42.63% | 97.52% | 74.46% | 74.46% | 96.10% |
| EPS Basic | 55.08% | 89.55% | 50.17% | 50.17% | 79.51% |
| Normalized Basic EPS | 55.39% | 89.71% | 74.79% | 74.79% | 79.58% |
| EPS Diluted | 55.08% | 89.55% | 50.17% | 50.17% | 79.51% |
| Normalized Diluted EPS | 55.39% | 89.71% | 74.79% | 74.79% | 79.58% |
| Average Basic Shares Outstanding | 4.37% | 4.95% | 0.94% | 0.94% | 0.88% |
| Average Diluted Shares Outstanding | 4.38% | 4.94% | 0.95% | 0.95% | 0.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |